In a preclinical study, treatment with S49076, an ATP-competitive tyrosine kinase inhibitor of MET, AXL, and FGFR1, significantly inhibited colony formation in soft agar by HCC cells overexpressing AXL and FGFR2 (61). The gene discussed is AXL; the disease is hepatocellular carcinoma.